COVID-19: What you need to know about the coronavirus pandemic on 18 December
Countries around the world are planning vaccination programmes. Image: REUTERS/Craig F. Walker
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
COVID-19
- This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
- Top stories: French PM Macron tests positive; EU states to start COVID-19 vaccinations from 27 December; Moderna vaccine set for US approval.
Have you read?
1. How COVID-19 is affecting the globe
Confirmed cases of COVID-19 have now passed 75 million globally, according to the Johns Hopkins Coronavirus Resource Center. The number of confirmed deaths stands at more than 1.66 million.
Two-thirds of England will be under the country's toughest 'Tier 3' COVID-19 measures from Saturday to tackle a rising number of infections.
Northern Ireland to set to enter six-week COVID-19 lockdown on December 26 to contain a surge in COVID-19 cases.
A new study from Singapore has shown that pregnant women don't get sicker than the wider population. It also found that babies born to infected mothers have antibodies against the virus.
A second wave of infections is hitting West and Central Africa with experts are warning it could be worse than the first, as cooler weather descends on the region.
Johnson & Johnson has enrolled 45,000 people into the first late-stage trial of its COVID-19 single-dose vaccine candidate. J&J plans to submit an emergency use authorization application to the U.S. Food and Drug Administration (FDA) in February if the data from the study is safe and effective.
South Korea has reported 1,062 new coronavirus cases, its second-highest ever daily tally.
Early data from the Phase I and II trials of the Oxford/AstraZeneca vaccine found it provoked a good immune response when a two full-dose regime is used.
The United States Food and Drug Administration is set to grant emergency approval to the Moderna COVID-19 vaccine.
What is the World Economic Forum doing about the coronavirus outbreak?
2. French President, Emmanuel Macron, tests positive for COVID-19
French President, Emmanuel Macron, tested positive for COVID-19 on Thursday and has gone into quarantine.
He joins a list of world leaders who've contracted the virus, which includes UK Prime Minister Boris Johnson, US President Donald Trump and Brazilian President Jair Bolsonaro.
Macron will cancel all upcoming trips, and the news has prompted track-and-trace efforts after recent meetings with leaders from across the EU.
3. EU states to start COVID-19 vaccinations
European Union states will start vaccinations against COVID-19 from 27 December, EU Commission chief Ursula von der Leyen has confirmed. The bloc is home to some 450 million people.
EU member states have been waiting for the European Medicines Agency (EMA) to approve the Pfizer/BioNTech vaccine. The EMA is expected to make an announcement on 21 December.
The EMA has also said it was speeding up efforts to approve the Moderna vaccine. It will bring forward a review to 6 January from 12 January.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Health and Healthcare SystemsSee all
Nikolaj Gilbert
September 12, 2024
Andy Moose, Kana Enomoto and Harris Eyre
September 9, 2024
Shyam Bishen and Oliver Eitelwein
September 3, 2024
Michael Purton
September 2, 2024
Shyam Bishen
August 30, 2024
Shyam Bishen
August 30, 2024